Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Recenti Progressi in Medicina
|
June 16, 2026
Maria Silvia Cona, Anna Rita Gambaro, Matteo De Monte, et al.
Cancer Reports (Hoboken, N.J.)
|
November 7, 2025
ICIs Exceptional Long Response in TNBC: Addressing the Issue of Optimal ICIs Duration. Two Cases and Review of the Literature
Simone Rota, Carolina Sciortino, Silvia Damian, et al.
Therapeutic Advances in Medical Oncology
|
September 15, 2025
Lenvatinib in advanced thyroid, salivary gland, endometrial, and hepatocellular carcinomas: a real-world study on treatment duration and toxicity management
Elena Colombo, Monika Ducceschi, Stefano Cavalieri, et al.
Cancer Medicine
|
April 28, 2023
Clinical efficacy of the first two doses of anti-SARS-CoV-2 mRNA vaccines in solid cancer patients
Maria Silvia Cona, Agostino Riva, Davide Dalu, et al.
Cancer Treatment Reviews
|
June 3, 2026
Adjuvant chemotherapy in stage I triple-negative breast cancer: A systematic review and meta-analysis of survival outcomes
Flavia Jacobs, Alessio Polymeropoulos, Matteo De Monte, et al.
Thyroid : Official Journal of the American Thyroid Association
|
June 24, 2026
Targeted Therapy-Induced Erythrocytosis in Thyroid Cancers: An Underrecognized Safety Signal from a Retrospective Study
Silvia Marchesi, Rebecca Romanò, Andrea Spagnoletti, et al.
NPJ Breast Cancer
|
December 13, 2025
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer
Emma Zattarin, Antonio Marra, Antonella Palazzo, et al.
Breast (Edinburgh, Scotland)
|
January 31, 2026
Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2
Giacomo Mazzoli, Leonardo Provenzano, Maria Vittoria Dieci, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Recenti Progressi in Medicina
|
June 16, 2026
Maria Silvia Cona, Anna Rita Gambaro, Matteo De Monte, et al.
Cancer Reports (Hoboken, N.J.)
|
November 7, 2025
ICIs Exceptional Long Response in TNBC: Addressing the Issue of Optimal ICIs Duration. Two Cases and Review of the Literature
Simone Rota, Carolina Sciortino, Silvia Damian, et al.
Therapeutic Advances in Medical Oncology
|
September 15, 2025
Lenvatinib in advanced thyroid, salivary gland, endometrial, and hepatocellular carcinomas: a real-world study on treatment duration and toxicity management
Elena Colombo, Monika Ducceschi, Stefano Cavalieri, et al.
Cancer Medicine
|
April 28, 2023
Clinical efficacy of the first two doses of anti-SARS-CoV-2 mRNA vaccines in solid cancer patients
Maria Silvia Cona, Agostino Riva, Davide Dalu, et al.
Cancer Treatment Reviews
|
June 3, 2026
Adjuvant chemotherapy in stage I triple-negative breast cancer: A systematic review and meta-analysis of survival outcomes
Flavia Jacobs, Alessio Polymeropoulos, Matteo De Monte, et al.
Thyroid : Official Journal of the American Thyroid Association
|
June 24, 2026
Targeted Therapy-Induced Erythrocytosis in Thyroid Cancers: An Underrecognized Safety Signal from a Retrospective Study
Silvia Marchesi, Rebecca Romanò, Andrea Spagnoletti, et al.
NPJ Breast Cancer
|
December 13, 2025
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer
Emma Zattarin, Antonio Marra, Antonella Palazzo, et al.
Breast (Edinburgh, Scotland)
|
January 31, 2026
Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2
Giacomo Mazzoli, Leonardo Provenzano, Maria Vittoria Dieci, et al.
Page
of 1